Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

Bullboard (NDAQ:LEXX)

View:
Post by Jonathon Brownon Jun 13, 2024 8:36am

Buzz on the Bullboards: TSX spotlight – Bombardier, Sonoro, PyroGenesis

Post by lscfaon Jun 03, 2024 6:50pm

Zacks fair value $8 US

https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_04292024_LEXX_Vandermosten.pdf
Post by shawkon Jun 03, 2024 4:23pm

Let's Toke Business

449582_5fcc34c0fab94b83b1de08806f21dace.pdf (letstoke.biz)
Post by whytestockson May 28, 2024 1:45pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosi

Just In: $LEXX Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024Lexaria, a global innovator in drug ...more  
Post by Yowza123on May 17, 2024 10:57am

Comprehensive GLP-1 Animal Study Begins Dosing

https://ir.lexariabioscience.com/news-events/press-releases/detail/250/dosing-begins-in-lexarias-comprehensive-glp-1-animal-study
Post by shawkon May 10, 2024 2:15pm

May Presentation

PowerPoint Presentation (d1io3yog0oux5.cloudfront.net)
Post by Yowza123on May 08, 2024 10:28am

Lexaria update on GLP-1 Human Pilot Study

https://ir.lexariabioscience.com/news-events/press-releases/detail/249/lexaria-begins-dosing-of-its-second-glp-1-human-pilot-study
Post by whytestockson May 06, 2024 5:00pm

InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ:

NEWS: $LEXX InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 DrugsLexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global ...more  
Post by whytestockson Apr 30, 2024 3:45pm

Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Ex

Breaking News: $LEXX Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and IssuanceKELOWNA, BC / ACCESSWIRE / April 30, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW ...more  
Post by ranmanon Apr 08, 2024 2:15pm

LD Micro Invitational XIV 2024

I'm interested to see if tomorrow's presentation motivates people to buy a few Lexaria Lexaria presents tomorrow at 10:30 am https://ldinv14.sequireevents.com/ Gatekeeper presents tomorrw at ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities